Advances in systemic and local therapies are helping more live longer with liver cancer and move forward after treatment as ...

Liver cancer screening uses ultrasound and AFP biomarker tests, with CT or MRI for further evaluation if abnormalities are ...

Available to treat adults with locally advanced or metastatic cholangiocarcinoma with an FGFR2 fusion or rearrangement PEMAZYRE ® (pemigatinib) is available via a co-pay access program in Australia ...

Editor’s note: This is a previously posted video, and the below is an automatically generated transcript to be used for informational purposes. Please notify [email protected] if there are concerns ...

In this webinar Julie Ann Lough is joined by three experts in the fields of oncology and pathology: Albrecht Stenzinger, ...

Primary sclerosing cholangitis (PSC) is a rare progressive liver disease that damages bile ducts and significantly increases the risk of bile duct cancer, particularly a type called cholangiocarcinoma ...

Gallbladder cancer and cholangiocarcinoma are both biliary cancers. They can cause the same symptoms, but causes and treatments can differ. Gallbladder cancer is cancer of the gallbladder, while ...

Ten years ago, Cholangiocarcinoma was a little known, little understood, rare disease, also known as an orphan cancer. This is no longer the case ever since the Cholangiocarcinoma Foundation was ...

– Using Invitae's Ciitizen patient-driven data platform, AstraZeneca and the Cholangiocarcinoma Foundation will access lived experience of patients with a rare cancer to drive further research – – ...